Castle Biosciences CCO Tobin W. sells $222,620 in shares
At a glance
- $CSTL today+0.70%last $32.98
- Vs industry peers+1.53 pts6-peer median −0.83% · ahead
- Since Nov 15−1.70%from the first trade after the story
- 52-week range25.5% below high$17.72 – $44.28
- Last reported loss$4.1Mquarter to Sep 30, 2026 · 10-Q
- In the headline$222,620Amount
Nothing reported about castle biosciences across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: That $222,620 isn't just a number — it's a clue. How does it stack up against the last few similar moves? That's where the real story lies.
- How the stock is trading: $CSTL +0.70% in the latest session.
- Timing: It was published over the weekend. The change shown is Friday's, and Monday is the first session that could react. Market holidays are not detected.
Where the stock stands
Castle Biosciences ($CSTL) edged up 0.70% to $32.98 in the latest session. Over the past month it is up 2.5%. It now sits 26% under the 52-week high of $44.28 and 86% above the year's low of $17.72. The year's high was 2.5 times its low, which makes double-digit swings fairly routine here.
What the filings say
In its latest report (10-Q, filed Nov 5, 2026), $CSTL lost $4.1M over the quarter to Sep 30, 2026 on revenue of $102.9M (-0.6% QoQ). Operations brought in $12.8M of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was negative at $15.8M. It carried $10.1M of debt against $78.0M of cash on Sep 30, 2026 — net cash of $67.9M. Its most recent filings before this story: 10-Q on Nov 5, 2026, 8-K on Nov 5, 2026, 10-Q on Jul 30, 2026. Figures are as filed with the SEC; the $CSTL page has the full statements.
How much coverage it is getting
Wook has filed 2 stories on Castle Biosciences in the last 30 days, 1 of them this week. That is well above its usual pace: over the month it has averaged less than one a week. Going by their wording, 1 read bullish, 1 neutral and 0 bearish. This one reads neutral, like most of them. This is the only one from Investing.com; the rest came from other outlets.
The bigger picture
In healthcare, timing is everything. A single trial result or FDA decision can shift a drug's fate, while broader policy changes ripple across the whole sector. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
Check the $CSTL filings first. They're the straight scoop, no spin. Wook AI can track how far the stock is from its high or compare this week's chatter with past coverage.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 15, 2026. $CSTL has moved -1.70% ($33.55 to $32.98). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
